Hardy Nathan — SEC Form 4 filings
SEC reporting owner CIK 1830053. 1 Form 4 filing on record with FilingPulse; latest filed 2024-03-08.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2024-03-08 to 2024-03-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | EVP, Chief Financial Officer | 1 | — | — | 2 |
Form 4 filings — Hardy Nathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-03-08 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 67,083 (derivative) @ $0 · Grant/award (A): 301,875 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830053 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →